C5AR1 and age-related macular degeneration: Tesidolumab: Tesidolumab is a C5 monoclonal IgG1 antibody that was initially developed to treat age-related macular degeneration, in which C5a and C5b deposition in Bruch’s membrane and retinal cells is observed.